Smith & Nephew plc (LON: SN)
London
· Delayed Price · Currency is GBP · Price in GBp
1,202.00
-6.50 (-0.54%)
Sep 11, 2024, 4:49 PM BST
Smith & Nephew Revenue
Smith & Nephew had revenue of $2.83B USD in the half year ending June 29, 2024, with 8.73% growth. This brings the company's revenue in the last twelve months to $5.64B, up 5.48% year-over-year. In the year 2023, Smith & Nephew had annual revenue of $5.55B with 6.40% growth.
Revenue (ttm)
$5.64B
Revenue Growth
+5.48%
P/S Ratio
2.35
Revenue / Employee
$305.77K
Employees
18,452
Market Cap
10.48B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
Dec 31, 2019 | 5.14B | 234.00M | 4.77% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 38.88B |
GSK plc | 31.45B |
Haleon plc | 11.26B |
ConvaTec Group PLC | 1.74B |
Hikma Pharmaceuticals PLC | 2.39B |
Oxford Nanopore Technologies plc | 167.75M |
Animalcare Group plc | 74.35M |
Smith & Nephew News
- 20 days ago - Smith & Nephew Delivering On Its Turnaround Promise - Seeking Alpha
- 5 weeks ago - Smith & Nephew plc (SNN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Smith & Nephew shares rise as profit beats market forecast - Reuters
- 2 months ago - Activist Cevian has a stake in Smith & Nephew. How it may help improve margins - CNBC
- 2 months ago - What's Driving Smith & Nephew PLC's Surprising 10% Stock Rally? - GuruFocus
- 2 months ago - Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge - Benzinga
- 2 months ago - Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge - Benzinga
- 2 months ago - Smith & Nephew rises as activist investor Cevian takes stake - Seeking Alpha